Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
annum, anti, anticancer, antitumor, borrower, borrowing, Carlo, checkpoint, chemotherapy, clause, cold, complimentary, Conservative, customary, cytotoxic, dampen, deep, default, DGCL, di, diagnosed, doctrine, duty, Eisai, embedded, expedient, Experimental, fiduciary, Fifteen, forefront, formation, Head, highlighting, HNSCC, hot, implicit, infancy, insolvency, Klein, left, lender, Leverage, leveraging, lien, loan, mediated, Medison, mice, modality, Monte, multicenter, neck, nonprovisional, onset, Pamela, payload, perfect, pledged, Pontifax, prepay, prioritize, radiation, radiotherapy, redirect, refocused, refractory, renegotiate, repayment, rollforward, ROU, routine, RSU, SAVI, Simulation, SLE, solid, Southwestern, spleen, SRC, suit, Suite, surgery, synergistic, Synlogic, thereon, thereunder, tranche, underscoring, vasculopathy, VWAP, weekly
Removed:
abrogate, acid, activate, addressable, Afdhal, affinity, agonism, Alnylam, analog, antagonism, antigen, antiviral, anxiety, Arrowhead, assembling, assembly, attached, Baraclude, baseline, bind, biomarker, Biopharma, bodily, body, Canada, capped, capsid, cccDNA, circular, clearance, combinatorial, composed, composite, comprising, contact, contingently, covalently, cure, daily, decoy, depression, detachable, discontinue, diseased, disoproxil, distinct, diversity, DNA, downregulate, downregulation, embody, employer, encode, encouraging, entecavir, evolved, expression, fever, finite, footnote, fumarate, function, functional, gene, Genentech, generically, glycol, HBeAg, HBsAg, HCV, hepatic, Hepatology, Hong, host, Iceland, immunity, immunological, immunomodulatory, improved, inactive, induced, inducing, infected, inhalation, inhibiting, injection, intracellular, invade, Janssen, JEEBO, journal, Kong, lamivudine, legally, Liechtenstein, load, memory, messenger, microbial, Micrologix, mild, modify, modulating, monthly, mood, move, multiply, nationalized, naturally, neuropsychiatric, Nezam, nonspecific, Norway, nucleic, nucleoside, occurring, oncological, optimization, orally, paper, pathogen, PEG, pegylated, phenotypic, phosphorothioate, polyethylene, polymerase, pooled, predictor, protective, protein, Radhakrishnan, randomized, ranged, receptor, recognizing, red, reducing, relying, replicate, replicating, replication, reproducing, repurchase, resemble, reservoir, resistant, restore, retinoic, retrospectively, revert, ribonucleic, RNA, scarring, screening, secondary, selectivity, sequentially, serum, signaling, siRNA, spread, stopping, stratified, structural, sublicensing, subsidiary, supportive, suppression, surface, synthesizing, Taiwan, tiered, transmitted, turning, uninfected, upregulate, usage, versatility, viability, Viread, week, white, Zealand
Filing tables
Filing exhibits
Related press release
FSTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Nos. 333-215122, 333-218399 and 333-234436) on Form S-3 and Registration Statement (Nos. 333-212047, 333-226508) on Form S-8 of Spring Bank Pharmaceuticals, Inc. of our report dated February 14, 2020, relating to the consolidated financial statements of Spring Bank Pharmaceuticals, Inc. and its subsidiaries, appearing in this Annual Report on Form 10-K of Spring Bank Pharmaceuticals, Inc. for the year ended December 31, 2019.
/s/ RSM US LLP
Boston, Massachusetts
February 14, 2020